|
|
|||||||||||||||||||||||
Article Navigation
|
Mesothelioma: New treatments for Mesothelioma cancerby: Hector Milla There are more treatment possibilities for Mesothelioma cancer than surgery, chemotherapy and radiation therapy: the clinical trials. They offer no only benefits, but also risks that cancer patients should know before taking part in one of these research studies. The U.S. National Cancer Institute sponsors clinical trials, because Mesothelioma cancer is difficult to control. This research is being performed to find out new treatments and better ways to use the current medical procedures. Clinical trials are performed before the application of any new treatment in human beings, because doctors should know if the treatment is safe for their patients and effective to fight the disease on the stage level in which is. Patients with mesothelioma can participate in research programs as a treatment option, because the possibility exists in the United States. People interested in take part in a clinical trial, however, should talk with their doctors before. There is information about clinical trials in the Cancer Information Service (CIS) of the above mentioned Institute or may call to the toll-free phone number 1–800–4–CANCER to talk to CIS staff who may identify and provide detailed information about specific ongoing clinical trials. The Web have various information about the subject, such as basic trial information, trial description with a summary and the eligibility criteria, and trial sites and contacts in the U.S. Latest Cancer News:FDA panel votes against Xgeva for prostate cancer A panel of cancer experts voted against a new use for Amgen's Xgeva in prostate cancer on Wednesday, saying the drug's ability to slow the spread of the disease did not translate into meaningful benefits for patients Breast cancer kills older women more often NEW YORK (Reuters Health) - Breast cancer is often considered more deadly among younger women, but a new study shows older women are actually more likely to die of the disease. Researchers found that among women who had been diagnosed with a certain type of breast cancer, those over 75 years old were 63 percent more likely to die of the cancer than women younger than 65. "I suspect it's ... Breast cancer charity chases Komen defectors As a prominent breast cancer researcher and activist, Susan Love is no stranger to the Susan G. Komen Foundation. Love runs a breast cancer research foundation that bears her name, and she organized the Army of Women , more than 360,000 women to whom breast cancer researchers can blast out requests for subjects. But the Komen Foundation is so entrenched in the world of breast cancer fundraising ... Doxil/Caelyx (Ovarian Cancer) - Analysis and Forecasts to 2020 NEW YORK, Feb. 8, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Doxil/Caelyx (Ovarian Cancer) - Analysis and Forecasts to 2020 http://www.reportlinker.com/p0657184/Doxil/Caelyx-Ovarian-Cancer---Analysis-and-Forecasts-to-2020.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=PathologyDoxil/Caelyx ... A Better Way to Spend Breast Cancer Funds? We must move breast cancer advocacy to the next level, beyond screening for cancers that are already there, even beyond the cure, to finding the cause, writes Dr. Susan Love. Cancer-hit cricketer Yuvraj vows to return stronger India's cancer-stricken World Cup hero Yuvraj Singh has vowed to return "stronger than ever" to competitive cricket, saying he was responding well to treatment in the United States. Triple Analysis: Lung Cancer, Angiogenesis and Cancer Vaccines NEW YORK, Feb. 8, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Triple Analysis: Lung Cancer, Angiogenesis and Cancer Vaccines http://www.reportlinker.com/p0284988/Triple-Analysis-Lung-Cancer-Angiogenesis-and-Cancer-Vaccines.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_MedicationThis ... Breast Cancer Drug May Weaken Bones, Study Finds TUESDAY, Feb. 7 (HealthDay News) -- A drug used to prevent breast cancer in women at high risk for the disease appears to cause bone loss in some postmenopausal women, a new study finds. Marian Regional Medical Center Receives CEO Cancer Gold Standard Accreditation The CEO Roundtable on Cancer recently accredited Marian Regional Medical Center with the CEO Cancer Gold Standard? recognizing the hospital?s efforts to reduce the risk of cancer f Marc Garnick Answers 6 Key Questions about Prostate Cancer Marc Garnick Answers 6 Key Questions about Prostate Cancer Breast cancer kills older women more often - Fox News
|
||||||||||||||||||||||
Copyright © 2006 CancerAdvice.org